MVEC viability is decreased over time in PEG-based hydrogels. by Rebecca A. Scott (488956)

Loss of Lsd1 in long bone mesenchymal cells leads to impaired ossification and growth. by Petri Rummukainen (4247122)

“…<p>(A) Lsd1 knockout mice have decreased body weight and length of tibia. …”

Activation of NMDA receptors with D-serine obviously limited the decrease of p-CREB in the hippocampus of the surviving LPS-treated mice. by Shuibing Zhang (4336402)

(R)-albuterol decreases cytokine protein levels in activated T cells by Marcela A Ferrada (41716)

“…</p><p></p> (R)-albuterol, (S)-albuterol or racemic albuterol (R + S) at a dose (10M) were added to T (EL-4) cells pre-activated with mitogens Concanavalin A (Con A, 5 μg/ml) and phorbol myristate acetate (PMA, 100 ng/ml) (CP). …”

(R)-albuterol decreases cytokine levels in activated murine splenocytes by Marcela A Ferrada (41716)

“…</p><p></p> (R)-albuterol (R), (S)-albuterol (S) or racemic albuterol (R + S) at a dose (10M) were added to murine splenocytes pre-activated with mitogens Concanavalin A (Con A, 5 μg/ml) and phorbol myristate acetate (PMA, 100 ng/ml) (CP), (Fig 3 A, B). …”

Move persistence estimates (γ_t) from the best-supported move persistence mixed-effects model fitted to Fastloc GPS location data from 22 naïve grey seal pups interpolate... by Benia V. R. Nowak (17054285)

Deletion of TXNIP decreases thioredoxin levels under hyperoxic conditions. by Mohammed A. Abdelsaid (287140)

“…<p>WT and TKO mice were subjected to 5 days hyperoxia (p7–12). Retinas were collected for protein and mRNA levels of thioredoxin (cytoplasmic Trx-1) (<b>A</b>) as well as mitochondrial Trx-2 (<b>B</b>) and total thioredoxin protein (<b>C</b>). …”

Legend for supporting information S2–S5. by Birgit Deboutte (19452787)

TGF-β decreases LPL mRNA expression in macrophages by Scott A. Irvine (26973)

Schematic of a shuffleboard task: the shuffleboard cue pushes the puck from rest and releases it at a position <i>x</i> with a velocity <i>v</i> when the contact force between puck and cue decreases to zero. by Joby John (245590)

Dexamethasone decreases PGC-1α protein expression and transcription. by Jill A. Rahnert (2872766)

“…<p>(A) Treatment of L6 myotubes with Dex (100nM, 48hrs) decreased PGC-1α protein expression (p = 0.01). n = 3/treatment from 3 experiments. …”

Dexamethasone decreases CRTC1 and CRTC2 nuclear localization. by Jill A. Rahnert (2872766)

“…<p>Treatment of L6 myotubes with Dex (100nM, 48hrs) decreased (A) total CRTC1 (p = 0.004 and CRTC2 protein (p = 0.0007). n = 9/treatment from 3 experiments. …”

Treatment with con-G showed improved neurological scoring and decreased peri-infarct Ca²⁺ microdeposits. by Rashna Balsara (714796)

ABCC3 overexpression decreases the retention of anti-cancer agents. by Sai A. Balaji (1452556)

Lsd1 inhibitor treatment in vivo. by Petri Rummukainen (4247122)

Fig 2 - by Daisuke Kume (14312076)

Increasing and decreasing trend in IgG levels among patients during different visits. by Ashraf Hassan Alzaabi (10960548)

Multi-way sensitivity analysis on transmission rate, CD4 count at diagnosis, and ART costs in a model-based analysis of Immediate ART initiation in Côte d’Ivoire. by Eric N. Ouattara (6890174)

The <i>Trypanosoma brucei</i> SNF2 ATPase complex exhibits characteristics of a SWR1 complex. by Tim Vellmer (12837414)

RL2 decreases viability and induces apoptosis in cultured cells. by Olga A. Koval (548122)